WENDY BULOW: Open Payments
NPI 1376579540 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,768 in 75 payments from 13 companies in 2025. Trend: 2023 $1,675 · 2024 $2,231 · 2025 $1,768
Food & beverage: $1,768
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $607 |
| GlaxoSmithKline, LLC. | 16 | $248 |
| Genentech USA, Inc. | 12 | $193 |
| Amgen Inc. | 4 | $145 |
| GENZYME CORPORATION | 8 | $143 |
| Novartis Pharmaceuticals Corporation | 6 | $108 |
| BioCryst US Sales Co., LLC | 2 | $108 |
| Regeneron Healthcare Solutions, Inc. | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Grifols USA, LLC | 2 | $45 |
Products named: TEZSPIRE, DUPIXENT, Xolair, FASENRA, NUCALA, ORLADEYO, TRELEGY ELLIPTA, Rhapsido.
Industry payments across CO — which companies pay providers there.
